| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.95B | 34.80B | 35.42B | 34.09B | 31.29B | 29.83B |
| Gross Profit | 10.99B | 10.97B | 11.17B | 10.12B | 9.60B | 9.45B |
| EBITDA | 2.90B | 2.89B | 3.07B | 2.38B | 2.08B | 1.91B |
| Net Income | 1.23B | 1.29B | 1.42B | 988.73M | 823.62M | 738.16M |
Balance Sheet | ||||||
| Total Assets | 33.07B | 33.64B | 33.66B | 31.36B | 30.27B | 29.53B |
| Cash, Cash Equivalents and Short-Term Investments | 8.89B | 9.50B | 8.99B | 8.54B | 8.33B | 7.88B |
| Total Debt | 3.34B | 3.84B | 3.83B | 3.61B | 3.60B | 3.81B |
| Total Liabilities | 12.73B | 13.25B | 14.18B | 13.03B | 12.71B | 12.61B |
| Stockholders Equity | 18.27B | 18.30B | 17.50B | 16.48B | 15.83B | 15.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | 1.37B | 639.73M | 948.76M | 623.27M |
| Operating Cash Flow | 0.00 | 2.23B | 2.41B | 1.11B | 1.78B | 1.21B |
| Investing Cash Flow | 0.00 | -993.79M | -1.46B | -443.35M | -684.06M | -568.92M |
| Financing Cash Flow | 0.00 | -730.63M | -492.73M | -454.03M | -630.46M | -509.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥24.30B | 9.70 | ― | 3.53% | 6.99% | -0.30% | |
79 Outperform | ¥62.99B | 12.92 | ― | 2.88% | 3.42% | 13.37% | |
77 Outperform | ¥12.93B | 11.64 | ― | 3.89% | -3.00% | -29.83% | |
77 Outperform | ¥7.53B | 6.49 | ― | 1.96% | 8.43% | 2.99% | |
66 Neutral | ¥34.66B | 11.93 | ― | 0.13% | 9.78% | 40.00% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Toho Acetylene Co., Ltd. has received approval from the Tokyo Stock Exchange to change its market segment listing from the Prime Market to the Standard Market, effective December 24, 2025. This strategic move aligns with the company’s focus on maintaining sufficient liquidity and governance levels while continuing to pursue growth and enhance corporate value. The company remains committed to improving its corporate governance and investor relations to meet shareholder expectations.
The most recent analyst rating on (JP:4093) stock is a Buy with a Yen401.00 price target. To see the full list of analyst forecasts on Toho Acetylene Co., Ltd. stock, see the JP:4093 Stock Forecast page.
Toho Acetylene Co., Ltd. reported a decline in its financial performance for the six months ended September 30, 2025, with net sales decreasing by 2.0% and profits showing significant reductions compared to the previous year. Despite the downturn, the company maintains a stable equity ratio, and there is no revision in the forecasted dividends or financial results for the fiscal year ending March 31, 2026, indicating a cautious but steady outlook.
The most recent analyst rating on (JP:4093) stock is a Buy with a Yen401.00 price target. To see the full list of analyst forecasts on Toho Acetylene Co., Ltd. stock, see the JP:4093 Stock Forecast page.